Phosphorus MR spectroscopy shows a tissue specific in vivo distribution of biochemical expression of the G3460A mutation in Leber's hereditary optic neuropathy

Occipital lobe and calf muscle energy metabolism were studied in vivo by magnetic resonance spectroscopy (31P-MRS) in four members of a family harbouring the mitochondrial DNA G3460A mutation causing Leber's hereditary optic neuropathy (LHON). Three siblings carried 100% mutated mitochondrial DNA (homoplasmy), while their mother had coexistence of mutated and wild-type mitochondrial DNA (heteroplasmy). Indices of brain energy metabolism on 31P-MRS were abnormal in all subjects examined, but the muscle oxidative phosphorylation rate was normal. These findings indicate a tissue specific distribution of the biochemical expression of the G3460A LHON mutation and suggest that extramitochondrial factors, such as nuclear genes, may influence expression of this mutation in vivo.

[1]  D. Manners,et al.  No correlation between muscle A3243G mutation load and mitochondrial function in vivo , 2001, Neurology.

[2]  D. Wallace,et al.  Functional Analysis of Lymphoblast and Cybrid Mitochondria Containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutation* , 2000, The Journal of Biological Chemistry.

[3]  B. Barbiroli,et al.  'Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. , 2000, Brain : a journal of neurology.

[4]  A. Gerinec,et al.  [Leber's hereditary optic neuropathy]. , 1999, Casopis lekaru ceskych.

[5]  C. Moraes,et al.  Suppression of a mitochondrial tRNA gene mutation phenotype associated with changes in the nuclear background. , 1999, Human molecular genetics.

[6]  J. Cooper,et al.  Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy , 1999, Journal of the Neurological Sciences.

[7]  A. Ghelli,et al.  Biochemical features of mtDNA 14484 (ND6/m64V) point mutation associated with Leber's hereditary optic neuropathy , 1999, Annals of neurology.

[8]  S. Tabrizi,et al.  The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy , 1998, Annals of neurology.

[9]  G. Radda,et al.  In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy , 1997, Annals of neurology.

[10]  P. Cortelli,et al.  Leber's hereditary optic neuropathy , 1997, Neurology.

[11]  H. Jacobs,et al.  Different cellular backgrounds confer a marked advantage to either mutant or wild-type mitochondrial genomes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Zaniol,et al.  Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation , 1995, Neurology.

[13]  P. Zaniol,et al.  in vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise , 1993, NMR in biomedicine.

[14]  M. Wikström,et al.  Electron transfer properties of NADH: Ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON) , 1991, FEBS letters.

[15]  D. Turnbull,et al.  Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. , 1991, American journal of human genetics.

[16]  R. Shulman,et al.  31P magnetization transfer studies of creatine kinase kinetics in living rabbit brain , 1987, Magnetic resonance in medicine.

[17]  Paul A. Bottomley,et al.  Depth-resolved surface-coil spectroscopy (DRESS) for in Vivo 1H, 31P, and 13C NMR , 1984 .

[18]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.

[19]  N. Howell.  Human mitochondrial diseases: answering questions and questioning answers. , 1999, International review of cytology.